384 related articles for article (PubMed ID: 30874827)
21. [Advances in the treatment of primary biliary cholangitis].
Li YM; Wang QX; Ma X
Zhonghua Gan Zang Bing Za Zhi; 2017 Nov; 25(11):805-809. PubMed ID: 29325272
[TBL] [Abstract][Full Text] [Related]
22. Clinical clues to suspicion of IgG4-associated sclerosing cholangitis disguised as primary sclerosing cholangitis or hilar cholangiocarcinoma.
Oh HC; Kim MH; Lee KT; Lee JK; Moon SH; Song TJ; Eum J; Park DH; Lee SS; Seo DW; Lee SK
J Gastroenterol Hepatol; 2010 Dec; 25(12):1831-7. PubMed ID: 21091993
[TBL] [Abstract][Full Text] [Related]
23. [Primary biliary cholangitis : an update].
Vieira Barbosa J; Vionnet J; Sciarra A; Sempoux C; Aubert V; Moradpour D; Fraga Christinet M
Rev Med Suisse; 2018 Aug; 14(616):1489-1494. PubMed ID: 30156781
[TBL] [Abstract][Full Text] [Related]
24. [A clinical and pathological analysis of 22 cases of primary sclerosing cholangitis].
Liu HH; Fu JL; Luo SQ; Sun YL; Dong JH; Guo TS; Wang FS
Zhonghua Gan Zang Bing Za Zhi; 2013 Feb; 21(2):125-8. PubMed ID: 23663885
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic performance of imaging criteria for distinguishing autoimmune cholangiopathy from primary sclerosing cholangitis and bile duct malignancy.
Gardner CS; Bashir MR; Marin D; Nelson RC; Choudhury KR; Ho LM
Abdom Imaging; 2015 Oct; 40(8):3052-61. PubMed ID: 26350286
[TBL] [Abstract][Full Text] [Related]
26. Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis: an Update on MR Imaging Findings with Recent Developments.
Kovač JD; Weber MA
J Gastrointestin Liver Dis; 2016 Dec; 25(4):517-524. PubMed ID: 27981308
[TBL] [Abstract][Full Text] [Related]
27. Ursodeoxycholic acid treatment of vanishing bile duct syndromes.
Pusl T; Beuers U
World J Gastroenterol; 2006 Jun; 12(22):3487-95. PubMed ID: 16773706
[TBL] [Abstract][Full Text] [Related]
28. Management of primary sclerosing cholangitis and its complications: an algorithmic approach.
Prokopič M; Beuers U
Hepatol Int; 2021 Feb; 15(1):6-20. PubMed ID: 33377990
[TBL] [Abstract][Full Text] [Related]
29. Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases.
Trauner M; Fickert P; Halilbasic E; Moustafa T
Wien Med Wochenschr; 2008; 158(19-20):542-8. PubMed ID: 18998069
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic role of bile acids and nuclear receptor agonists in fibrosing cholangiopathies.
Trauner M; Halilbasic E; Kazemi-Shirazi L; Kienbacher C; Staufer K; Traussnigg S; Hofer H
Dig Dis; 2014; 32(5):631-6. PubMed ID: 25034298
[TBL] [Abstract][Full Text] [Related]
31. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
Maggiore G; Riva S; Sciveres M
Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308
[TBL] [Abstract][Full Text] [Related]
32. Clinical Management of Primary Biliary Cholangitis-Strategies and Evolving Trends.
Gao L; Wang L; Woo E; He X; Yang G; Bowlus C; Leung PSC; Gershwin ME
Clin Rev Allergy Immunol; 2020 Oct; 59(2):175-194. PubMed ID: 31713023
[TBL] [Abstract][Full Text] [Related]
33. Immune-mediated cholangiopathies in children: the need to better understand the pathophysiology for finding the future possible treatment targets.
Grama A; Mititelu A; Sîrbe C; Benţa G; Pop TL
Front Immunol; 2023; 14():1206025. PubMed ID: 37928553
[TBL] [Abstract][Full Text] [Related]
34. Obeticholic acid for the treatment of primary biliary cholangitis in adult patients: clinical utility and patient selection.
Bowlus CL
Hepat Med; 2016; 8():89-95. PubMed ID: 27621676
[TBL] [Abstract][Full Text] [Related]
35. Primary sclerosing cholangitis.
Stiehl A; Benz C; Sauer P
Can J Gastroenterol; 2000 Apr; 14(4):311-5. PubMed ID: 10799084
[TBL] [Abstract][Full Text] [Related]
36. Primary sclerosing cholangitis.
Alba LM; Angulo P; Lindor KD
Minerva Gastroenterol Dietol; 2002 Jun; 48(2):99-113. PubMed ID: 16489301
[TBL] [Abstract][Full Text] [Related]
37. [Cholestatic liver diseases].
Thimme R; Opitz OG; Blum HE; Kreisel W
Ther Umsch; 2004 Aug; 61(8):521-7. PubMed ID: 15457969
[TBL] [Abstract][Full Text] [Related]
38. Treatment of primary biliary cholangitis ursodeoxycholic acid non-responders: A systematic review.
Suraweera D; Rahal H; Jimenez M; Viramontes M; Choi G; Saab S
Liver Int; 2017 Dec; 37(12):1877-1886. PubMed ID: 28517369
[TBL] [Abstract][Full Text] [Related]
39. [Gastrointestinal endoscopy in the diagnosis and treatment of biliary liver disease].
Liang XY; Ding HG
Zhonghua Gan Zang Bing Za Zhi; 2022 Jul; 30(7):690-695. PubMed ID: 36038336
[TBL] [Abstract][Full Text] [Related]
40. [Treatment of cholestatic liver diseases with ursodeoxycholic acid].
Boberg KM; Schrumpf E
Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
